Conformal radiotherapy for prostate cancer

Annals of Medicine

Volumn 32, Issue 1, 2000, Pages 57-63

  Hanks, Gerald E ^a,b  

^a FOX CHASE CANCER CENTER   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

Conformal treatment; External beam irradiation; Prostate cancer

Indexed keywords

CLINICAL TRIAL; COMPLICATION; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; HUMAN; IMMOBILIZATION; MALE; MEDICAL EDUCATION; META ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RADIATION DOSE; REVIEW;

EID: 0033967328     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853890008995911     Document Type: Review

References (32)

1. Hanks GE, Schultheiss TE, Hanlon AL, Hunt M, Lee WR, Epstein BE, et al. Dose escalation in the conformal treatment of prostate cancer: optimization is made possible by understanding the dose responses for control of cancer and late morbidity. Int J Radiat Oncol Biol Phys 1996; 36: 197.
2. Hanks GE, Hanlon AL, Schultheiss TE, Pinover WH, Movsas B, Epstein BE, et al. Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization and future directions. Int J Radiat Oncol Biol Phys 1998; 41: 501-10.
3. Hanks GE. Strategies for improving the outcome of patients with poor prognosis prostate cancer. Acta Oncol 1998; 37: 5-10.
4. Zelefsky M, Leibel S, Gaudin P, Kutcher G, Fleshner N, Venkatramen E, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998; 41: 491-500.
5. Hanks GE, Schultheiss TE, Hunt MA, Epstein B. Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1995; 31: 25-9.
6. Zelefsky MJ, Leibel SA, Kutcher GJ, Kelson S, Ling C, Fuks Z. The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma. Cancer J Sci Am 1995; 1: 142-50.
7. Fukanaga-Johnson N, Sandler HM, McLaughlin W, Strawderman MS, Grijalva KH, Kish KE, et al. Results of 3D conformal radiotherapy in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 1997; 38: 311-8.
8. Sandler HM, Perez-Tamayo C, Ten Haken RK, Lichter AS. Dose escalation for stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapy. Radiother Oncol 1992; 23: 53-4.
9. Soffen EM, Hanks GE, Hwang CC, Chu JCH. Conformal static field therapy for low volume low grade prostate cancer with rigid immobilization. Int J Radiat Oncol Biol Phys 1991; 20: 141-6.
10. Kagawa K, Lee WR, Schultheiss TE, Hunt MA, Shaer AH, Hanks GE. Initial clinical assessment of CT-MRI image fusion software in localization of the prostate for 3D conformal radiation therapy. Int J Radiat Oncol Biol Phys 1997; 38: 319-25.
11. Roach M, Faillace-Akazawa P, Malfatti C, Holland J, Hricak H. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 1996; 35: 1011-8.
12. McShan DL, Fraass BA, Lichter AS. Full integration of the beams eye view concept in computerized treatment planning. Int J Radiat Oncol Biol Phys 1990; 18: 1489-94.
13. Nishidai T, Nagata Y, Takahashi M, Abe M, Yamaoka N, Ishihara K, et al. CT simulator: a new 3-D planning and simulating system for radiotherapy. Part 1: Description of system. Int J Radiat Oncol Biol Phys 1990; 18: 499-504.
14. Takahashi S. Conformation radiotherapy. Acta Radiol Suppl 1965; 1: 142.
15. Umegaki Y. Dose distribution in the moving field radiotherapy. Nippon Acta Radiol 1960; 20: 2191-209.
16. Michalski J, Purdy J, Winter K, Roach M, Vijayakumar S, Sandler H, et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys (in press).
17. Hanks G, Hanlon A, Pinover W, Horwitz E, Price R, Schultheiss T. Dose selection for prostate cancer patients based on dose comparison and dose response studies. Int J Radiat Oncol Biol Phys (in press).
18. Leibel SA, Heimann R, Kutcher GJ, Zelefsky MJ, Burman CB, Melain E, et al. Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a Phase I dose-escalation study. Int J Radiat Oncol Biol Phys 1993; 28: 55-65.
19. Ling C, Burman C, Chui CS, Jackson A, Kutcher GJ, Leibel S, et al. Perspectives of multidimensional conformal radiation treatment. Radiother Oncol 1993; 29: 129-39.
20. Ling CC, Burman C, Chui C, Kutcher GJ, Leibel SA, LoSasso T, et al. Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys 1996; 35: 721-30.
21. LoSasso T, Chui C, Kutcher G, Leibel S, Fuks Z, Ling C. The use of a multi-leaf collimator for conformal radiotherapy of carcinomas of the prostate and nasopharynx. Int J Radiat Oncol Biol Phys 1993; 25: 161-70.
22. Mohan R, Mageras G, Baldwin B, Brewster L, Kutcher G, Leibel S, et al. Clinically relevant optimization of 3D conformal treatments. Med Phys 1992; 19: 933-44.
23. Wurzer J, Nicolaou N, Hanlon A, Watkins-Bruner D, Hanks G. Long term durability of potency preservation in younger prostate cancer patients following 3D conformal radiation therapy (abstract). Int J Radiat Oncol Biol Phys 1999; 45(2 Suppl): 169.
24. Pound CR, Partin AW, Epstein JI, Walsh PC. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Urol Clin North Am 1997; 24: 395-406.
25. Hanlon A, Bruner D, Hanks G. Long term quality of life study in prostate cancer patients treated with three dimensional conformal radiation therapy: bowel and bladder quality of life symptoms are similar to that of the normal population (abstract). Int J Radiat Oncol Biol Phys 1999; 45(2 Suppl): 240.
26. Hanks G. The case for external beam treatment of early stage prostate cancer. Urology (in press).
27. Shipley W, Thames H, Sandler H, Hanks G, Zietman A, Perez C, et al. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA 1999; 281: 1558-604.
28. Pollack A, Zagars G. External beam radiotherapy dose response of prostate cancer. Int J Radiat Oncol Biol Phys 1997; 39: 1011-8.
29. Rasch C, Barilot I, Remeijer P, Touw A, M v H, Lebesque J. Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys 1999; 43: 57-66.
30. Milosevic M, Voruganti S, Blend R, Alasti H, Warde P, McLean M, et al. Magnetic resonance imaging (MRI) for localization of the prostatic apex: comparison to computed tomography (CT) and urethrography. Radiother Oncol 1998; 47: 277-84.
31. Lattanzi J, McNeely S, Pinover W, Horwitz E, Das I, Price R, et al. A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer. Int J Radiat Oncol Biol Phys 1999; 43: 719-25.
32. Lattanzi J, McNeeley S, Hanlon A, Schultheiss T, Hanks G. Ultrasound-based stereotactic guidance of precision conformal external beam radiation therapy in clinically localized prostate cancer. Urology (in press).